Table 1.
Clinical characteristics of the HCC patients used in this study.
| TCGA cohort | LIRI-JP cohort | |
|---|---|---|
| No. of patients | 371 | 260 |
| Age | ||
| Median (range) | 61 (16–90) | 69 (31–89) |
| ≤ 65 (%) | 230 (62.0%) | 98 (37.7%) |
| >65 (%) | 141 (38.0%) | 162 (62.3%) |
| Gender (%) | ||
| Female | 120 (32.3%) | 68 (26.2%) |
| Male | 251 (67.7%) | 192 (73.8%) |
| Grade (%) | ||
| Grade 1 | 55 (14.8%) | NA |
| Grade 2 | 178 (50.0%) | NA |
| Grade 3 | 120 (32.3%) | NA |
| Grade 4 | 13 (3.5%) | NA |
| Unknown | 5 (1.4%) | NA |
| Stage (%) | ||
| I | 174 (46.9%) | 40 (15.4%) |
| II | 85 (22.9%) | 117 (45.0%) |
| III | 84 (22.6%) | 80 (30.8%) |
| IV | 4 (1.1%) | 23 (8.8%) |
| Unknown | 24 (6.5%) | 0 (0.0%) |
| T (%) | ||
| T1 | 185 (49.1%) | NA |
| T2 | 95 (25.2%) | NA |
| T3 | 81 (21.5%) | NA |
| T4 | 13 (3.4%) | NA |
| Tx | 3 (0.8%) | NA |
| N (%) | ||
| N0 | 257 (68.2%) | NA |
| N1 | 4 (1.1%) | NA |
| Nx | 116 (30.7%) | NA |
| M (%) | ||
| M0 | 272 (72.1%) | NA |
| M1 | 4 (1.1%) | NA |
| Mx | 101 (26.8%) | NA |